MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

11 Feb 2022 Evaluate
The Sales for the quarter ended December 2021 of Rs. 1.60 million declined by -85.55% from Rs. 11.07 millions.The Company to register a -62.61%  fall in the net profit for the quarter ended December 2021.Operating profit for the quarter ended December 2021 decreased to 1.92 millions as compared to 4.66 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 1.60 11.07 -85.55 2.19 24.70 -91.13 69.91 33.96 105.86
Other Income 4.08 5.41 -24.58 12.13 11.04 9.87 14.66 14.65 0.07
PBIDT 1.92 4.66 -58.80 4.95 9.73 -49.13 23.12 10.59 118.32
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 1.92 4.66 -58.80 4.95 9.73 -49.13 23.12 7.95 190.82
Depreciation 0.23 0.14 64.29 0.55 0.42 30.95 0.58 0.58 0.00
PBT 1.69 4.52 -62.61 4.40 9.31 -52.74 22.54 7.37 205.83
TAX 0.00 0.00 0.00 0.00 -0.06 0.00 8.05 -0.17 -4835.29
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 4.48 -0.20 -2340.00
PAT 1.69 4.52 -62.61 4.40 9.37 -53.04 14.49 7.54 92.18
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 120.00 42.10 185.06 226.03 39.39 473.78 33.07 31.18 6.05
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..